LYC Healthcare, which operates orthopedic surgery and diagnostic imaging clinics in Singapore, filed on Monday with the SEC to raise up to $15 million in an initial public offering.
The Singapore-based company plans to raise $15 million by offering 3 million shares at a price range of $4 to $6. At the midpoint of the proposed range, LYC Healthcare would command a market cap of $128 million.
LYC Healthcare is a multidisciplinary specialist healthcare provider in Singapore offering an integrated suite of musculoskeletal services throughf five medical clinics and in-house advanced imaging facilities. It delivers computer-navigated total hip and knee replacements, keyhole and minimally invasive procedures, alongside MRI, CT, X-ray, BMD and ultrasound imaging, and on-site physiotherapy via a three-year collaboration. The company treats patients with degenerative joint diseases, spine conditions, sports injuries, metabolic diseases and osteoporosis, providing care from health screenings and diagnostic scans to treatment and rehabilitation.
The Singapore, Singapore-based company was founded in 2024 and booked $13 million in revenue for the 12 months ended March 31, 2025. It plans to list on the Nasdaq but has not yet chosen a ticker (RC ticker: LYCH.RC). AC Sunshine Securities is the sole bookrunner on the deal.
